Frontal lobe fALFF measured from resting-state fMRI as a prognostic biomarker in first-episode psychosis.

MLA

Lencz, Todd, et al. “Frontal Lobe FALFF Measured from Resting-State FMRI as a Prognostic Biomarker in First-Episode Psychosis.” Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 47, no. 13, Dec. 2022, pp. 2245–51. EBSCOhost, https://doi.org/10.1038/s41386-022-01470-7.

APA

Lencz, T., Moyett, A., Argyelan, M., Barber, A. D., Cholewa, J., Birnbaum, M. L., Gallego, J. A., John, M., Szeszko, P. R., Robinson, D. G., & Malhotra, A. K. (2022). Frontal lobe fALFF measured from resting-state fMRI as a prognostic biomarker in first-episode psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 47(13), 2245–2251. https://doi.org/10.1038/s41386-022-01470-7

Chicago

Lencz, Todd, Ashley Moyett, Miklos Argyelan, Anita D Barber, John Cholewa, Michael L Birnbaum, Juan A Gallego, et al. 2022. “Frontal Lobe FALFF Measured from Resting-State FMRI as a Prognostic Biomarker in First-Episode Psychosis.” Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 47 (13): 2245–51. doi:10.1038/s41386-022-01470-7.